4
Views
0
CrossRef citations to date
0
Altmetric
Special Report

The adolescent gynecology patient

&
Pages 49-56 | Published online: 10 Jan 2014

References

  • American College of Obstetricians and Gynecologists. A Guideline for Women’s Health Care (Second Edition). ACOG, Washington DC, USA (2002).
  • American College of Obstetricians and Gynecologists. Tool Kit for Teen Care. ACOG, Washington DC, USA (2003).
  • American College of Obstetricians and Gynecologists. Primary and Preventive Care: periodic assessments. ACOG Committee Opinion No. 292. Obstet. Gynecol.102(5), 1117–1124 (2003).
  • American College of Obstetricians and Gynecologists. Management of abnormal cervical cytology and histology. ACOG Practice Bulletin No. 66. Obstet. Gynecol.106(3), 645–664 (2005).
  • Harper DM, Franco EL, Wheeler C et al.; GlaxoSmithKline HPV Vaccine Study Group. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomized controlled trial. Lancet364, 1757–1765 (2004).
  • Villa LL, Costa RL, Petta CA et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomized double-blind placebo-controlled multicentre Phase II efficacy trial. Lancet Oncol.6, 271–278 (2005).
  • Kent S, Legro R. Polycystic ovary syndrome in adolescents. Adolesc. Med.13, 73–88 (2002).
  • Rotterdam ESHRE/ASRM sponsored PCOS Consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovarian syndrome. Fertil. Steril.81, 19–25 (2004).
  • Sir-Petermann T, Maliqueo M, Angel B, Lara H, Perez-Bravo F, Recabarren S. Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization. Hum. Reprod.17, 2573–2579 (2002).
  • Fleischman A, Mansfield J. Diagnosis and treatment of polycystic ovarian syndrome and insulin resistance. Pediatr. Ann.34, 733–742 (2005).
  • Ferriman D, Gallwey J. Clinical assessment of body hair in women. J. Clin. Endocrinol. Metab.24, 1440–1445 (1961).
  • Buggs C, Rosenfield RL. Polycystic ovary syndrome in adolescence. Endocrinol. Metab. Clin. North Am.34, 677–705 (2005).
  • Mavropoulos J, Yancy W, Hepburn J, Westman E. The effects of a low-carbohydrate, ketogenic diet on the polycystic ovary syndrome: a pilot study. Nutrit. Metabol.2, 35–40 (2005).
  • Darroch JE, Singh S, Frost JJ. Differences in teenage pregnancy rates among five developed countries: the roles of sexual activity and contraceptive use. Fam. Plann. Perspect.33, 244–250 (2001).
  • Smith CA. Factors associated with early sexual activity among urban adolescents. Soc. Work42, 334–346 (1997).
  • Thomas MH. Abstinence-based programs for prevention of adolescent pregnancies. A review. J. Adolesc. Health26, 5–17 (2000).
  • Hewitt G, Cromer B. Update on adolescent contraception. Obstet. Gynecol. Clin. North Am.27, 143–162 (2000).
  • Anderson FD, Hait H. A multicenter, randomized study of an extended cycle oral contraceptive. Contraception68, 89–96 (2003).
  • Lara-Torre E, Schroeder B. Adolescent compliance and side effects with Quick Start initiation of oral contraceptive pills. Contraception66, 81–85 (2002).
  • Graham S, Fraser IS. The progestogen-only mini-pill. Contraception26, 373–388 (1982).
  • Lara-Torre E, Edwards CP, Perlman SE, Hertweck SP. Prospective study evaluating bone mineral density in adolescent females using Depo-Provera. J. Pediatr. Adolesc. Gynecol.17(1), 17–21 (2004).
  • Cromer BA, Lazebnik R, Rome E et al. Double-blinded randomized controlled trial of estrogen supplementation in adolescent girls who receive depot medroxyprogesterone acetate for contraception. Am. J. Obstet. Gynecol.192, 42–47 (2005).
  • Scholes D, LaCroix AZ, Ichikawa LE, Barlow WE, Ott SM. Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception. Arch. Pediatr. Adolesc. Med.159, 139–144 (2005).
  • Le J, Tsourounis C. Implanon: a critical review. Ann. Pharmacother.35(3), 329–236 (2001).
  • Task Force on Postovulatory Methods of Fertility Regulation. Randomized controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Lancet353, 428–432 (2001).
  • Cheng L, Gulmezoglu AM, Oel CJ, Piaggio G, Ezcurra E, Look PF. Interventions for emergency contraception. Cochrane Database Syst. Rev. (3), CD001324 (2004).
  • Belzer M, Uoshida E, Tejirian R et al. Advanced supply of emergency contraception for adolescent mothers increased utilization without reducing condom or primary contraception use. J. Adol. Health32, 122–123 (2003).
  • Minnis AM, Shiboski SC, Padian NS. Barrier contraceptive method acceptability and choice are not reliable indicators of use. Sex. Transm. Dis.30, 556–561 (2003).
  • Stuart GS, Castano PM. Sexually transmitted infections and contraceptives: selective issues. Obstet. Gynecol. Clin. North Am.30, 795–808 (2003).
  • Grimes DA, Schulz KF. Prophylactic antibiotics for intrauterine device insertion: a metaanalysis of the randomized controlled trials. Contraception60, 57–63 (1999).
  • Emans SJ, Grace E, Woods ER et al. Adolescents’ compliance with the use of oral contraceptives. JAMA257(24), 3377–3381 (1987).
  • Laufer M, Grotein D, Bush M, Cramer D, Emans SJ. Prevalence of endometriosis in adolescent girls with chronic pelvic pain not responding to conventional therapy. J. Pediatr. Adolesc. Gynecol.10, 199–202 (1997).
  • American College of Obstetricians and Gynecologists. Endometriosis in adolescents. ACOG Committee Opinion No. 310. Obstet. Gynecol.105, 921–927 (2005).

Website

  • FDA warning on the contraceptive patch www.fda.gov/bbs/topics/news/2005/NEW01262.html

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.